motesanib   Click here for help

GtoPdb Ligand ID: 5660

Synonyms: AMG 706 | AMG-706
PDB Ligand
Compound class: Synthetic organic
Comment: Motesanib is a pan-VEGFR inhibitor that was investigated for anti-tumourigenic efficacy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 78.94
Molecular weight 373.19
XLogP 2.99
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C
Isomeric SMILES O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C
InChI InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)
Bioactivity Comments
Motesanib potently inhibits pro-angiogenic activity induced by VEGF receptor activation, and is equipotent at all three receptor isoforms [2]. Additionally this compound inhibits platelet-derived growth factor receptor, and stem cell factor receptor activity.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
kinase insert domain receptor Primary target of this compound Hs Inhibitor Inhibition 8.6 pKd - 1
pKd 8.6 (Kd 2.6x10-9 M) [1]
fms related receptor tyrosine kinase 1 Hs Inhibitor Inhibition 8.7 pIC50 - 2
pIC50 8.7 (IC50 2x10-9 M) [2]
kinase insert domain receptor Hs Inhibitor Inhibition 8.5 pIC50 - 2
pIC50 8.5 (IC50 3x10-9 M) [2]
fms related receptor tyrosine kinase 4 Hs Inhibitor Inhibition 8.2 pIC50 - 2
pIC50 8.2 (IC50 6x10-9 M) [2]